Package 67877-491-60

{"route": ["ORAL"], "spl_id": "69fcef14-1e86-4d26-9fcd-95e6084d6173", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "unii": ["GLH0314RVC"], "rxcui": ["1116635"], "spl_set_id": ["2f73a4db-2c7f-4e42-a914-87aedc2780fb"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (67877-491-60)", "package_ndc": "67877-491-60", "marketing_start_date": "20250430"}], "brand_name": "Ticagrelor", "product_id": "67877-491_69fcef14-1e86-4d26-9fcd-95e6084d6173", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "67877-491", "generic_name": "Ticagrelor", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA208567", "marketing_category": "ANDA", "marketing_start_date": "20250430", "listing_expiration_date": "20261231"}